IFNB1 and Mental deterioration: As cognitive decline occurs in the absence of ongoing relapse or disability progression even in the early stages of disease [21], our findings suggest that early IFN-β treatment may not only protect those with cognitive symptoms from further cognitive decline, but may also prevent the development of cognitive impairment.